Germany Market Trends Germany is one of the most developed markets for GLP-1 analogues in Europe, given the high rate of therapy uptake and effective healthcare reimbursement systems
Then he watched them fail his own mother during menopause
Heres a comparison to semaglutide showing that the novel compound leads to more weight loss (blue dots are semaglutide, red dots are the new compound, black dots are placebo, and the Y-axis is body weight): Hitting different receptors may also mean an impact on tolerability - one of the big issues with these medications in the real world
Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ
What is your budget
Additionally, this supports the increased circulating GLP-1 levels observed in Glp1r / mice (Lamont et al., 2012), albeit the intact receptor is required for improved post-prandial lipid tolerance